ABSTRACT
Farnesyltransferase inhibitors (FTIs) have emerged as promising anti-cancer drugs (1, 2) . These compounds inhibit protein farnesyltransferase, an enzyme that catalyzes farnesylation of proteins ending with the CAAX motif (C is cysteine, A is an aliphatic amino acid, and X is the C-terminal amino acid) (1) (2) (3) . FTIs inhibit anchorage-independent growth of a variety of transformed cells (4, 5) . A survey of cancer cell lines has shown that Ͼ70% of cells are sensitive to FTI (6) . In addition, FTIs have been shown to inhibit the growth of tumors in a number of animal model studies (7) (8) (9) (10) . In one case, regression of mammary tumors in transgenic mice expressing activated H-ras was observed (10) . These promising drugs currently are being assessed in clinical trials (11) .
Remarkably, FTIs show little effects on untransformed cells (2) . Furthermore, FTIs did not exhibit any significant toxicity in animal studies (2) . This specific effect of FTIs on transformed cells raises the possibility that farnesylated proteins play critical roles in maintaining transformed phenotypes. Although farnesylation of Ras initially was thought to be responsible for the effects of FTIs, a number of recent observations raise the possibility that farnesylation of proteins other than Ras is important for the effects of FTIs (2, 12) . First, it has been shown that FTIs are incapable of inhibiting the modification of K-ras and N-ras. Instead of accumulating as unmodified proteins, they are modified by a geranylgeranyl group in the presence of FTIs (13, 14) . Second, FTIs inhibit transformed phenotypes of cancer cell lines irrespective of whether they contain mutated ras (6) . An increasing number of farnesylated proteins, in addition to Ras, have been identified (12) . These include members of the Rho-family of G proteins such as RhoB (15, 16) and RhoE (17) , another G protein Rheb (18) as well as inositol-1,4,5-triphosphate 5-phosphatase (19, 20) and cyclic nucleotide phosphodiesterase (21, 22) .
Because the phenotypes induced by FTIs may provide hints about farnesylated proteins critical for maintaining transformed phenotypes, we have initiated a study to characterize effects of FTIs on the physiology of transformed cells. Although a variety of biological effects of FTIs including inhibition of soft agar growth, morphological reversions (23, 24) , cell cycle progression (25, 26) , and induction of apoptosis (apoptosis of tissue culture cells is seen only when cells are denied attachment to substratum) (25, 27) has been reported, a clear picture of the effect of FTIs on transformed cells has not emerged. In this work, we focused on morphological changes induced by FTIs with the hope to investigate the effects of FTIs on cellular cytoskeletons. To carry out a detailed investigation of the FTI-induced morphological changes, we took advantage of transformed cells that exhibit a round morphology. Changes of the morphology of such cells would be dramatic and should enable us to investigate associated cytoskeletal changes. After examining a number of transformed cell lines, we realized that v-K-ras-transformed NRK cells (KNRK) provide a suitable system. In this paper, we present evidence that FTIs cause dramatic morphological changes of KNRK cells and that microtubules play an important role in these changes. Immunof luorescence and Western Blotting. To visualize polymerized actin, cells were fixed in 4% paraformaldehyde for 10 min, permeabilized with 0.5% Triton X-100 for 10 min, and incubated with 1 g͞ml fluorescein isothiocyanate-labeled phalloidin (Sigma) for 1 h. Antibody against actin (Sigma) also was used for indirect immunofluorescence. For microtubule localization, cells were fixed with Ϫ80°C methanol͞acetone (1:1) for 10 min and permeabilized with 0.5% Triton X-100 for 10 min. They were incubated with a 1:2,000 dilution of the monoclonal ␣-tubulin antibody B-5-1-2 (Sigma) for 1 h at 37°C. This was followed by a 45-min incubation with a 1:1,000 dilution of fluorescein isothiocyanate-conjugated goat antimouse IgG (Sigma). Cells were viewed on a Nikon microscope and photographed with Kodax T-MAX 400 film. Western blotting was carried out according to the method described in ref. 13 . mAb TM311 against high molecular weight isoforms of tropomyosin was obtained from Sigma.
Flow Cytometry. Cells treated with or without FTI were analyzed by propidium iodide staining and flow cytometry with a FACScan flow cytometer (Becton Dickinson Immunocytometry Systems) as described (30) . Histograms were analyzed for cell cycle compartment by using CELLQUEST software (Becton Dickinson Immunocytometry Systems). Ten thousand events were collected to maximize the statistical validity of the compartmental analysis. Percentage of live cells was determined by staining cells with 7-aminoactinomycin D (31) . This procedure also determines the percentage of apoptotic cells and dead cells.
RESULTS

FTI Causes Morphological
Changes of v-K-ras-Transformed NRK Cells. To identify a transformed cell line that exhibits dramatic morphological changes in response to the addition of FTIs, we examined a number of established cancer cell lines. From this survey, we found that FTIs cause distinct morphological changes of v-K-ras-transformed NRK cells (KNRK). In most of the studies reported in this paper, we used SCH56582, a tricyclic compound that acts as a competitive inhibitor of farnesyltransferase with respect to its substrate protein (24) . This compound is effective in inhibiting anchorageindependent growth of transformed cells (13, 24) . We also have confirmed that the growth of KNRK cells on soft agar is inhibited by SCH56582 (data not shown). The effects of SCH56582 on the morphology of KNRK cells are shown in Fig.  1 . KNRK cells have a round morphology ( Fig. 1 A) whereas untransformed NRK cells have an elongated (flattened and stretched) morphology (Fig. 1C) . After the addition of SCH56582, the round KNRK cells became elongated, and extensions were seen (Fig. 1B) . In contrast, no changes were seen with the morphology of untransformed NRK cells by the addition of SCH56582 (compare Fig. 1 C and D) . The FTIinduced morphological changes of KNRK cells depend on SCH56582 concentration. Approximately 50% of cells exhibited elongated morphology after the treatment with 10 M SCH56582, and the percentage of cells with this altered morphology reached Ϸ75% with 20 M SCH56582 treatment ( Fig. 2A) . In contrast, we did not see any effects of these concentrations of SCH56582 on NRK cells at least up to 48 h. Concentrations Ͼ60 M interfered with the growth of both KNRK and NRK cells. The time course of the morphological changes ( Fig. 2B) shows that the changes occur by 24 h after the addition of SCH56582, and Ͼ60% of cells change their morphology by 36 h after the SCH56582 addition. The effects of SCH56582 on the morphology of KNRK cells appear to be reversible because round cells reappeared 3 days after the removal of SCH56582 (data not shown).
Similar morphological changes were observed with a different type of inhibitor, B1088 (8), a peptidomimetic of a CAAX peptide, CVFM; 60 M B1088 caused Ϸ70% of cells to change their morphology (data not shown). SCH56582 also induced morphological changes in tumorigenic, metastatic mouse lung epithelial cells, Spon5 and Spon8 (29) ; Ͼ70% of these round cells became elongated in response to 24 h of treatment with 20 M SCH56582 (data not shown).
FTI Does Not Restore Actin Cytoskeleton Disrupted in KNRK Cells. To investigate further the mechanisms involved in the morphological changes caused by FTI, we examined the actin cytoskeleton by indirect immunofluorescence of cells (Fig. 3) . NRK cells stained with phalloidin showed extensive actin cytoskeleton networks as seen by their typical fiber-like appearance (Fig. 3A) . In contrast, fiber-like staining was not observed with KNRK cells, and the phalloidin staining was observed more at the cell periphery (Fig. 3B ). Phalloidin staining of KNRK cells after the treatment with SCH56582 was similar to that seen with the untreated KNRK cells (Fig. 3C) ; although cell morphology was changed, the staining still was detected at the periphery of cells. Staining with anti-actin antibody also showed that SCH56582 failed to restore the disrupted actin cytoskeleton in KNRK cells (data not shown). SCH56582 also failed to induce focal adhesion plaques; typical punctate staining by anti-vinculin antibody was not observed (data not shown). We also examined effects of FTI on tropomyosin, which is involved in the regulation of actin cytoskeleton. It has been reported that NRK cells express three isoforms of high molecular weight tropomyosin, TM-1, TM-2, and TM-3, and that TM-2 and TM-3 are missing in KNRK cells (32) . In agreement with this report, we detected TM-1 but not TM-2 or TM-3 in heat-treated extracts of KNRK cells, whereas all three tropomyosin isoforms were detected in heat-treated extracts of NRK cells. Treatment of KNRK cells with 20 M SCH56582 did not influence this tropomyosin expression pattern in KNRK cells, and neither TM-2 nor TM-3 was detected (data not shown). Taken together, these results suggest that SCH56582 does not affect the actin cytoskeleton. 
FTI Causes Significant Effects on Microtubule Networks.
In contrast to the lack of effects on the actin cytoskeleton, we observed significant effects of SCH56582 on microtubule networks. Fig. 4 shows indirect immunofluorescence of cells stained with anti-␣-tubulin antibody. Typical extensive microtubule fibers were found in NRK cells (Fig. 4A) . In contrast, microtubule networks were much less extensive in KNRK cells; the anti-tubulin staining in KNRK cells was more predominant at the cell periphery (Fig. 4B) . A region of intense staining also is seen in the cytoplasm, presumably representing that of the microtubule organization center. The addition of SCH56582 led to the expansion of the microtubule networks, and extensive fibers now are observed in the FTI-treated KNRK cells (Fig. 4C) . Western analyses showed that the level of ␣-and ␤-tubulins in KNRK cells was not significantly different from that in NRK cells and that these levels were not affected by the addition of SCH56582 (data not shown). Thus, it appears that SCH56582 causes a significant change of the microtubule networks rather than affecting the synthesis of tubulins.
Microtubule Interfering Agents Block the FTI-Induced Morphological Changes of KNRK Cells. The appearance of extensive networks of microtubules in the FTI-treated KNRK cells raises the possibility that microtubule extension is important for the FTI-induced morphological changes. Alternatively, FTI induces morphological changes by a mechanism independent of microtubules and that microtubule extension occurs as a consequence of the morphological change. To investigate these points, we used vincristine or vinblastine, compounds that interfere with the dynamic process of microtubule assembly. Fig. 5 shows the effects of vincristine on FTI-induced morphological changes. As can be seen, vincristine effectively blocked the FTI-induced morphological changes (Fig. 5, compare D to B and A) . The block of FTI-induced morphological changes of KNRK cells can be obtained with vincristine concentrations as low as 1.2 nM. At this low concentration, vincristine alone does not exhibit any significant effects on the morphology of KNRK cells (data not shown) and does not affect cell cycle progression (see below; Table 1 ). A similar block of the FTI-induced morphological changes was obtained with vinblastine or with colchicine (data not shown). In marked contrast to the results obtained with microtubule-interfering agents, the addition of 2.1 M cytochalasin B, a compound that interferes with actin polymerization, did not affect the FTI-induced morphological changes of KNRK cells (Fig. 5C ). Although it is not obvious in Fig. 5 , we did observe a small percentage of binucleated cells among KNRK cells treated with FTI plus cytochalasin B. Cytochalasin B alone does not exhibit any significant effects on morphology and cell cycle progression of KNRK cells (data not shown). We also examined whether vincristine used to block the above FTI-induced morphological changes affected cell cycle distribution of KNRK cells. As can be seen in Table 1 
DISCUSSION
An implication of the present study is that microtubule dynamics play critical roles in the effects of FTI on KNRK cells. Extensive microtubule networks are seen readily with untransformed NRK cells, but such networks are less extensive in KNRK cells. The addition of FTI to KNRK cells results in dramatic morphological changes and reappearance of extensive microtubule networks (Fig. 4) . This suggests that FTI induces the extension of microtubules in the cytoplasm. We speculated that, if this were the case, the addition of microtubule interfering agents such as vincristine or vinblastine would block FTI-induced morphological changes of KNRK cells. This was shown to be the case with SCH56582-or B1088-induced morphological changes. In addition, FTIinduced changes of Spon8 cells were sensitive to vincristine. Microtubules are under dynamic equilibrium between polymers and tubulin monomers͞dimers. Binding of vincristine to tubulin monomers and dimers upsets this equilibrium (33) and blocks microtubule extension. We noted that the concentration of vincristine needed to block the FTI-induced morphological changes could be as low as 1.2 nM. At this concentration, no significant effects on cell cycle distribution were observed. FTI may be involved in a step in the restoration of microtubule networks that requires a particularly high concentration of tubulin monomers and dimers, and this step is highly sensitive to the addition of vincristine.
The effect of FTI on microtubule dynamics also may explain our observation that the addition of both FTI and vincristine causes enrichment of G 2 ͞M phase cells. This synergistic effect of vincristine and FTI was seen at a concentration of vincristine 10 times higher than that required to block the FTI-induced morphological changes. During mitosis, microtubules completely reorganize to carry out chromosome segregation. The reorganization of microtubules requires dynamic and highly regulated polymerization and depolymerization events. Interference of this dynamic process by the binding of vincristine to tubulin monomers and dimers results in the enrichment of G 2 ͞M phase cells. FTI might interfere further with this dynamic by incorrectly providing a signal for microtubule extension when it is necessary to depolymerize microtubules. A similar synergistic effect of FTI and a microtubule drug was reported by Moasser et al. (34) who showed that FTI significantly enhanced taxol-induced arrest of MCF-7 breast cancer cells at the G 2 ͞M phase.
If one of the critical functions of FTI is to affect microtubule dynamics, it is possible that farnesylated proteins are involved in the modulation of microtubules. It may be the case that farnesylated proteins associate with microtubules and directly affect their regulation. In this regard, it is interesting to note that cyclic nucleotide phosphodiesterase (CNPase) (21, 22) has been reported to be associated with microtubules (35) . There are two isoforms of CNPase, CNP1 (46 kDa) and CNP2 (48 kDa), and both contain the C-terminal CysThrIleIle sequence. Characterization of these proteins showed that they can be modified by either a farnesyl or a geranylgeranyl group (36) . Additional investigation is needed to examine the prenylation status of CNP1 and CNP2 proteins in KNRK cells and to see whether FTI blocks farnesylation of these proteins.
An alternative possibility for how FTI can modulate microtubule dynamics is that FTI affects a signaling pathway that is involved in the regulation of proteins affecting microtubules. Posttranslational modifications of these proteins such as microtubule associated proteins (MAPs) are believed to be critical for the stability of microtubules. Possibly, farnesylated proteins activate such protein kinases. An example of a class of protein kinases modulating microtubule functions is extracellular signal-regulated kinases (ERKs) also known as mitogen-activated protein kinases (MAPKs). Constitutive activation of ERKs by the expression of a mutant form of MAPK kinase is associated with morphological rounding and a loss of cytoskeletal organization, whereas the inhibition of ERK activity leads to cytoskeletal organization and morphological flattening of transformed NIH 3T3 cells (37, 38) . Expression of a mutant form of ERK2 also affects cytoskeletal organization (39) . Association of ERKs with microtubules places these kinases in close proximity to microtubule-associated proteins (40) . Activity of protein kinases similar to ERKs might be affected by FTI. We do not believe that FTI affects ERKs because FTI does not alter the expression and activation of ERK1 and ERK2 in KNRK cells (unpublished observation). Furthermore, FTI does not affect modification of v-K-ras protein, which functions upstream of ERKs. The addition of FTI did not result in the appearance of unmodified v-K-ras protein on a SDS polyacrylamide gel, whereas such unmodified proteins were detected with extracts from mevinolin-treated cells (unpublished observation). Investigation of signaling pathways affected by FTI should provide further insights into the action of FTI. In conclusion, we have obtained evidence that FTI affects microtubule dynamics. Additional work to examine whether FTI causes any biochemical changes in microtubules as well as in proteins associating with microtubules may be informative. This line of investigation may provide hints about the identity of farnesylated proteins affected by FTI, and this may lead to our understanding of the roles of farnesylated proteins in maintaining transformed phenotypes.
